Essais liés5clinical trials
VillePontiaclocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03984448

Ouvrir le site du centre

Essais cliniques associés

5
MoléculeIndication / populationPhaseNCTTitreStatut
Biospecimen Collection Cancer Phase 2 NCT06770582 Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial RECRUITING
Biospecimen Collection Cancer Phase 3 NCT04269902 Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study RECRUITING
Biospecimen Collection SEP Phase 2/3 NCT03984448 Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas ACTIVE_NOT_RECRUITING
Biopsy Procedure Cancer Phase 2/3 NCT04628767 Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer RECRUITING
Biospecimen Collection Cancer Phase 3 NCT04267848 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) RECRUITING